Antonio-David Lázaro-Sánchez

5PUBLICATIONS
12CO-AUTHORS
International trade and investment lawCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology not elsewhere classifiedMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidence.

|Aug 29, 2025
Adding Docetaxel to Tepotinib to Overcome Oligoprogression in MET Exon 14 Skipping-Mutated NSCLC When Local Therapy Is Unfeasible: A Case Report.

David Sánchez García, Beatriz Grau Mirete, Paula Rodríguez Payá

|Aug 14, 2025
Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions.

Fátima Postigo-Corrales, Asunción Beltrán-Videla, Antonio David Lázaro-Sánchez

|Feb 26, 2025
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report.

Antonio David Lazaro Sanchez, Javier David Benitez Fuentes, Ginés Luengo Gil

|Nov 22, 2019
HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancer.

A D Lázaro-Sánchez, P Salces-Ortiz, L I Velásquez

Pageof 1

Frequent Collaborators

2 joint publications

Javier-David Benítez-Fuentes

2 joint publications

Ginés Luengo-Gil

2 joint publications

Pablo Conesa-Zamora

2 joint publications

Ana Belén Arroyo Rodríguez